Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells - PubMed (original) (raw)
Case Reports
doi: 10.1038/nm0196-52.
Affiliations
- PMID: 8564842
- DOI: 10.1038/nm0196-52
Case Reports
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
F J Hsu et al. Nat Med. 1996 Jan.
Abstract
In this pilot study, we investigated the ability of autologous dendritic cells pulsed ex vivo with tumor-specific idiotype protein to stimulate host antitumor immunity when infused as a vaccine. Four patients with follicular B-cell lymphoma received a series of three or four infusions of antigen-pulsed dendritic cells followed, in each instance, by subcutaneous injections of soluble antigen two weeks later. All patients developed measurable antitumor cellular immune responses. In addition, clinical responses have been measured with one patient experiencing complete tumor regression, a second patient having partial tumor regression, and a third patient resolving all evidence of disease as detected by a sensitive tumor-specific molecular analysis.
Similar articles
- Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.
Di Nicola M, Zappasodi R, Carlo-Stella C, Mortarini R, Pupa SM, Magni M, Devizzi L, Matteucci P, Baldassari P, Ravagnani F, Cabras A, Anichini A, Gianni AM. Di Nicola M, et al. Blood. 2009 Jan 1;113(1):18-27. doi: 10.1182/blood-2008-06-165654. Epub 2008 Sep 22. Blood. 2009. PMID: 18809757 Clinical Trial. - A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
Koç ON, Redfern C, Wiernik PH, Rosenfelt F, Winter JN, Carter WD, Gold DP, Stewart ME, Ghalie RG, Bender JF. Koç ON, et al. J Immunother. 2010 Feb-Mar;33(2):178-84. doi: 10.1097/CJI.0b013e3181bfcea1. J Immunother. 2010. PMID: 20145546 Clinical Trial. - Dendritic cells: potential role in cancer therapy.
Engleman EG. Engleman EG. Cytotechnology. 1997;25(1-3):1-8. doi: 10.1023/a:1007997918593. Cytotechnology. 1997. PMID: 9474803 Free PMC article. Review. - Translational development of vaccination strategies in follicular NHL.
Sakamaki I, Qin H, Kwak LW. Sakamaki I, et al. Best Pract Res Clin Haematol. 2011 Jun;24(2):295-304. doi: 10.1016/j.beha.2011.03.007. Epub 2011 May 6. Best Pract Res Clin Haematol. 2011. PMID: 21658625 Review.
Cited by
- Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study.
Van den Bossche J, De Laere M, Deschepper K, Germonpré P, Valcke Y, Lamont J, Stein B, Van Camp K, Germonpré C, Nijs G, Roelant E, Anguille S, Lion E, Berneman Z. Van den Bossche J, et al. PLoS One. 2024 Jul 15;19(7):e0307204. doi: 10.1371/journal.pone.0307204. eCollection 2024. PLoS One. 2024. PMID: 39008481 Free PMC article. - Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy.
Kumari K, Singh A, Chaudhary A, Singh RK, Shanker A, Kumar V, Haque R. Kumari K, et al. Vaccines (Basel). 2024 May 5;12(5):498. doi: 10.3390/vaccines12050498. Vaccines (Basel). 2024. PMID: 38793749 Free PMC article. Review. - Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K, Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M, Caluwaert K, Nijs G, Cools N, Verlooy J, Norga K, Verhulst S, Anguille S, Berneman Z, Lion E. Van Genechten T, et al. BMJ Open. 2024 Mar 18;14(3):e077613. doi: 10.1136/bmjopen-2023-077613. BMJ Open. 2024. PMID: 38503417 Free PMC article. - Dendritic Cells in Cancer Immunology and Immunotherapy.
Hato L, Vizcay A, Eguren I, Pérez-Gracia JL, Rodríguez J, Gállego Pérez-Larraya J, Sarobe P, Inogés S, Díaz de Cerio AL, Santisteban M. Hato L, et al. Cancers (Basel). 2024 Feb 28;16(5):981. doi: 10.3390/cancers16050981. Cancers (Basel). 2024. PMID: 38473341 Free PMC article. Review. - Dendritic cells as orchestrators of anticancer immunity and immunotherapy.
Heras-Murillo I, Adán-Barrientos I, Galán M, Wculek SK, Sancho D. Heras-Murillo I, et al. Nat Rev Clin Oncol. 2024 Apr;21(4):257-277. doi: 10.1038/s41571-024-00859-1. Epub 2024 Feb 7. Nat Rev Clin Oncol. 2024. PMID: 38326563 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical